Harm Reduction Therapeutics
  • Our Story
  • OTC RiVive®
  • Why 3 mg?
  • Contact Us
  • Login
  • My Account
  • Buy Now
  • What Is Harm Reduction
  • Resources
  • News
  • Events
  • FAQ
  • Partner Offerings
  • What Is Harm Reduction?
  • Resources
  • News
  • Events
  • FAQ
  • Partner Offerings
Harm Reduction Therapeutics Announces that its Naloxone Nasal Spray Met its Primary Endpoints in a Phase 1 Clinical Trial

Harm Reduction Therapeutics Announces that its Naloxone Nasal Spray Met its Primary Endpoints in a Phase 1 Clinical Trial

by Brian Shim | Mar 1, 2022 | News

What’s Taking So Long  for Naloxone to Be Made  Available Over the  Counter?

What’s Taking So Long for Naloxone to Be Made Available Over the Counter?

by Brian Shim | Jan 18, 2019 | News

HRT CEO Dr. Hufford presents at the FDA’s Advisory Committee Meeting on the Availability Naloxone

HRT CEO Dr. Hufford presents at the FDA’s Advisory Committee Meeting on the Availability Naloxone

by Brian Shim | Dec 18, 2018 | News

The costs of heroin and naloxone: a tragic snapshot of the opioid crisis

The costs of heroin and naloxone: a tragic snapshot of the opioid crisis

by Brian Shim | Nov 8, 2018 | News

Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States

Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States

by Brian Shim | Sep 5, 2018 | News

HRT CEO Dr. Hufford presents at the Nicholas Hall Conference

HRT CEO Dr. Hufford presents at the Nicholas Hall Conference

by Brian Shim | Jul 5, 2018 | News

« Older Entries
Next Entries »
  • Contact Us
  • Privacy Policy
  • Accessibility
  • FAQ
  • Follow
  • Follow
  • Follow
  • Follow

© Copyright 2025 Harm Reduction Therapeutics, Inc. All Rights Reserved. To report Adverse Events contact: customercare@harmreductiontherapeutics.org.